Disclosures for "Microglia PET Imaging Pre- and Post- Anti-amyloid Treatment with Lecanemab: A Case Study"
-
Mrs. Johnson has nothing to disclose.
-
Dr. Smith has nothing to disclose.
-
Mr. Guzman has nothing to disclose.
-
Miss Houlihan has nothing to disclose.
-
Dr. Sanchez has nothing to disclose.
-
Dr. Small has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for Frontotemporal Dementia. Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAGE Pharmaceuticals.
-
Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
-
Prof. Lao has nothing to disclose.